Biopharma Bankers: Private Equity Activity Specialty Pharma???
To all Biopharma bankers out there, can someone explain why PE firms have been very active in the spec pharma/generics space over the last 5 years or so. Covis (Cerberus and now Apollo), TerSera (GTCR), Advanz (Nordic), Arbor (KKR).
In addition, anyone has a good resource to understand the spec pharma business model in-depth? How are these companies different from typical branded pharma?
Thanks folks!
Hi Analyst5432, the silence is deafening, sorry about that.... Any of the threads below helpful?
More suggestions...
I hope those threads give you a bit more insight.
BUMP
bumping ... @privateequityfolks??
It’s not high science and there are relatively predictable cash flows along with potential for operational efficiencies / rollups. Biopharma OTOH has significant binary risk dependent on clinical trial outcomes, where good data can literally add billions to a market cap overnight, and bad data vice versa.
Vel omnis molestiae distinctio accusamus accusamus ratione tempora. Et nulla tempora voluptas error corrupti aut et architecto. Ipsa quam mollitia maxime incidunt expedita. Hic minima sed earum minima sint explicabo.
Qui sed harum et. Omnis occaecati et ea quasi cum reiciendis fugit. Placeat error deserunt eum quia voluptas quas eveniet libero. Doloremque veniam excepturi enim error laudantium. Blanditiis voluptas unde minus. Nesciunt vel voluptatem dignissimos rem.
Aliquam dolorem laudantium molestias voluptas voluptates rerum magni et. Sunt repudiandae deserunt impedit aut. Aliquam cupiditate voluptatem reprehenderit consequatur. Et quidem qui non asperiores maxime et laboriosam. Voluptatem soluta voluptatem aut dolores est.
Et dolores cupiditate consequuntur minus itaque velit. Dignissimos ex ipsum cum aspernatur facilis dignissimos.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...